Get the Stockscreener App
113.76
0.10%
0.11
Pre-market:
113.56
-0.20
-0.18%
Irhythm Holdings Inc stock is traded at $113.76, with a volume of 204.57K.
It is up +0.10% in the last 24 hours and down -0.21% over the past month.
iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
See More
Previous Close:
$113.65
Open:
$114.64
24h Volume:
204.57K
Relative Volume:
0.40
Market Cap:
$3.74B
Revenue:
$787.85M
Net Income/Loss:
$-27.78M
P/E Ratio:
-131.12
EPS:
-0.8676
Net Cash Flow:
$18.75M
1W Performance:
+6.09%
1M Performance:
-0.21%
6M Performance:
-32.69%
1Y Performance:
-20.92%
1-Day Range:
$112.39
$115.32
1-Week Range:
$107.80
$118.08
52-Week Range:
$101.75
$212.00
Irhythm Holdings Inc Stock (IRTC) Company Profile
Name
Irhythm Holdings Inc
Sector
Industry
Phone
415-632-5700
Address
699 8TH STREET, San Francisco, CA
Compare IRTC vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IRTC
Irhythm Holdings Inc
|
113.76 | 3.74B | 787.85M | -27.78M | 18.75M | -0.8676 |
ABT
Abbott Laboratories
|
88.67 | 154.45B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
307.94 | 118.05B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
80.38 | 103.20B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
46.76 | 69.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.28 | 49.68B | 6.30B | 1.07B | 1.09B | 1.8406 |
Irhythm Holdings Inc Stock (IRTC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-05-26 | Upgrade | Evercore ISI | In-line → Outperform |
| Sep-23-25 | Initiated | Evercore ISI | In-line |
| Aug-20-25 | Initiated | BofA Securities | Buy |
| May-02-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-03-24 | Resumed | Wells Fargo | Equal Weight |
| Oct-04-24 | Initiated | Goldman | Neutral |
| Jun-20-24 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Dec-11-23 | Upgrade | Citigroup | Neutral → Buy |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Feb-07-23 | Initiated | Wells Fargo | Overweight |
| Nov-07-22 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Jun-09-22 | Downgrade | Citigroup | Buy → Neutral |
| Apr-06-22 | Initiated | Wolfe Research | Underperform |
| Feb-24-22 | Upgrade | Needham | Hold → Buy |
| Jan-18-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jan-12-22 | Upgrade | BTIG Research | Neutral → Buy |
| Jan-11-22 | Upgrade | Oppenheimer | Perform → Outperform |
| Dec-21-21 | Resumed | Canaccord Genuity | Buy |
| Dec-17-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-15-21 | Upgrade | Citigroup | Neutral → Buy |
| Jun-02-21 | Downgrade | Citigroup | Buy → Neutral |
| Apr-13-21 | Downgrade | BTIG Research | Buy → Neutral |
| Apr-12-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-26-21 | Downgrade | Colliers Securities | Buy → Neutral |
| Jan-29-21 | Reiterated | Needham | Hold |
| Nov-17-20 | Downgrade | Oppenheimer | Outperform → Perform |
| Sep-11-20 | Initiated | Needham | Hold |
| Sep-02-20 | Initiated | Robert W. Baird | Neutral |
| Aug-07-20 | Upgrade | Colliers Securities | Neutral → Buy |
| Aug-05-20 | Upgrade | Oppenheimer | Perform → Outperform |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-06-20 | Initiated | BTIG Research | Buy |
| Jan-10-20 | Initiated | William Blair | Outperform |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Oct-22-19 | Initiated | Oppenheimer | Perform |
| Feb-20-19 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| Sep-13-18 | Reiterated | Canaccord Genuity | Buy |
| Sep-06-18 | Initiated | Chardan Capital Markets | Buy |
| Aug-02-18 | Upgrade | Dougherty & Company | Sell → Neutral |
| Jul-16-18 | Downgrade | Dougherty & Company | Neutral → Sell |
| Dec-01-17 | Initiated | Dougherty & Company | Neutral |
View All
Irhythm Holdings Inc Stock (IRTC) Latest News
iRhythm discloses cybersecurity incident (IRTC:NASDAQ) - Seeking Alpha
iRhythm Holdings, Inc. 8-K SEC Filing June 2026 – Company Details, Address, and Stock Information - Minichart
iRhythm discloses cyber incident, says no impact on device systems, patient safety - Reuters
Cyberattack at iRhythm (NASDAQ: IRTC) involves PHI but no system outage - Stock Titan
iRhythm Holdings (IRTC) Hovers Near Resistance as Consolidation ContinuesInside Day Breakout - newsline.com
iRhythm Holdings (IRTC) Grinds Higher as Stock Holds Above Key Support LevelCalendar Spread Trade - newsline.com
IRTC Q1 2026 Earnings: Strong EPS Beat Amidst Absent Revenue DisclosureMargin Expansion Trends - newsline.com
Why iRhythm Holdings, Inc. (IRTC) is a top momentum stock for the long term - MSN
iRhythm Holdings (IRTC) Slides 1.08% as Support Levels Come into FocusStock Picks - newsline.com
IRTC Reiterated by BTIG -- Price Target Maintained at $185 - GuruFocus
Q1 2026 iRhythm Holdings, Inc Earnings Call Transcript - GuruFocus
iRhythm Holdings, Inc at Bank of America Global Healthcare Conference Transcript - GuruFocus
How iRhythm’s Governance Overhaul and Shelf Registration Could Reshape the Risk Profile for IRTC Investors - simplywall.st
iRhythm Holdings, Inc. (IRTC) Stock Analysis: Navigating a 65% Potential Upside in the Medical Devices Sector - DirectorsTalk Interviews
iRhythm Holdings (IRTC) Edges Higher as Stock Tests Key Resistance ZoneEqual Weight ETF - newsline.com
IRTC Q1 2026 Earnings: EPS Beats Estimates by Wide Margin but Revenue Not ReportedEarnings Weakness Phase - newsline.com
A Look At iRhythm Holdings (IRTC) Valuation After Governance Changes And Litigation Settlement - Yahoo Finance
IRTC Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Mild Stock UptickRevenue Surprise History - newsline.com
iRhythm Holdings (IRTC) Posts Modest Gain, Maintains Support Above $102.7AD Line Divergence - newsline.com
iRhythm Holdings, Inc. Files Form 8-K with SEC – Company Details, Stock Symbol IRTC, and NASDAQ Listing Information - Minichart
iRhythm Holdings (IRTC) was Trimmed Following Strong Performance - Insider Monkey
iRhythm reaches $45M settlement to resolve securities class action - TradingView
iRhythm Holdings (NASDAQ: IRTC) agrees to $45M securities class action settlement - Stock Titan
iRhythm (NASDAQ: IRTC) EVP sells 1,716 shares to cover RSU taxes - Stock Titan
iRhythm (NASDAQ: IRTC) CAO acquires ESPP shares, sells some for taxes - Stock Titan
iRhythm Holders Back Governance Shift As Shares Trade Below Estimates - Sahm
IRTC: FDA-cleared algorithm, strong Q1 growth, and primary care expansion drive raised outlook - TradingView
IRTC Maintained by Canaccord Genuity -- Price Target Lowered to $152 - GuruFocus
iRhythm (IRTC) chief commercial & product officer acquires 177 ESPP shares - Stock Titan
iRhythm Holdings (IRTC) executive adds 137 ESPP shares, holds 55,043 - Stock Titan
iRhythm (IRTC) EVP adds shares through 2016 Employee Stock Purchase Plan - Stock Titan
iRhythm (IRTC) CEO Blackford adds 178 shares via 2016 ESPP plan - Stock Titan
2 Reasons to Like IRTC and 1 to Stay Skeptical - Yahoo Finance
IRhythm Holdings, Inc. (IRTC) Stock Analysis: Riding The Wave Of A 57% Potential Upside - DirectorsTalk Interviews
iRhythm Holdings Inc. (IRTC) Q1 2026 Earnings: EPS Beat Signals Cost Discipline Amid Strategic ShiftsUpward Estimate Revision - The Legal Advocate
iRhythm Holdings (IRTC) director granted 1,573 RSUs in equity award - Stock Titan
Director Bruce Bodaken of iRhythm (NASDAQ: IRTC) receives 1,573 RSUs in equity grant - Stock Titan
Director at iRhythm (IRTC) receives 1,573 RSU equity award, now holds 11,141 shares - Stock Titan
Director at iRhythm (IRTC) granted 1,573 restricted stock units in equity award - Stock Titan
Director at iRhythm (NASDAQ: IRTC) receives 1,573 RSU award - Stock Titan
Director at iRhythm Holdings (IRTC) receives 1,573 restricted stock units - Stock Titan
Director at iRhythm (IRTC) awarded 1,573 restricted stock units in Form 4 - Stock Titan
iRhythm Holdings, Inc. Files Form 8-K Reporting Annual Shareholder Meeting Results and Company Details (May 27, 2026) - Minichart
iRhythm (IRTC) shareholders approve 2026 equity plan, directors and auditor - Stock Titan
IRTC: All five proposals, including director elections and governance changes, were approved - TradingView
iRhythm Holdings, Inc Annual Shareholders Meeting Transcript - GuruFocus
iRhythm Holdings (IRTC) Slides 1.9% as Stock Tests Key Support ZoneBuyback Factor - newsline.com
IRhythm Holdings, Inc. (IRTC) Stock Analysis: Exploring A 55% Upside Potential - DirectorsTalk Interviews
Here's why you should retain IRTC stock in your portfolio for now - MSN
What iRhythm Holdings (IRTC)'s Sustained Zio Growth and 2027 AI Launch Plan Means For Shareholders - Sahm
Digital health firm iRhythm lines up June investor conference talks - Stock Titan
Irhythm Holdings Inc Stock (IRTC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.35%
0.87%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):